132 Chapter 5 doi:10.1016/j.psyneuen.2019.03.029 79. Veenman L, et al. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis. J Bioenerg Biomembr. Jun 2008;40(3):199-205. doi:10.1007/s10863-0089142-1 80. Veenman L, et al. Potential involvement of F0F1ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines : a mechanism for induction of apoptosis via the 18 kDa mitochondrial translocator protein. Apoptosis. Jul 2010;15(7):753-68. doi:10.1007/ s10495-010-0460-5 81. Veenman L, et al. The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression. Curr Mol Med. May 2012;12(4):398-412. doi:10.2174/1566524011207040398 82. Azarashvili T, et al. The peripheral-type benzodiazepine receptor is involved in control of Ca2+-induced permeability transition pore opening in rat brain mitochondria. Cell Calcium. Jul 2007;42(1):27-39. doi:10.1016/j.ceca.2006.11.004 83. Zulian A, et al. The translocator protein (peripheral benzodiazepine receptor) mediates rat-selective activation of the mitochondrial permeability transition by norbormide. Biochim Biophys Acta. Dec 2011;1807(12):1600-5. doi:10.1016/j. bbabio.2011.08.007 84. Galiegue S, et al. The peripheral benzodiazepine receptor: a promising therapeutic drug target. Curr Med Chem. Aug 2003;10(16):1563-72. doi:10.2174/0929867033457223 85. Katz Y, et al. Increase in peripheral benzodiazepine binding sites in colonic adenocarcinoma. Oncology. 1990;47(2):139-42. doi:10.1159/000226806 86. Lacapere JJ, et al. Insight into the Structural Features of TSPO: Implications for Drug Development. Trends Pharmacol Sci. Dec 18 2019;doi:10.1016/j. tips.2019.11.005 87. Li H, et al. Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology. Dec 1998;139(12):4991-7. doi:10.1210/endo.139.12.6390 88. Li H, et al. Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc Natl Acad Sci U S A. Jan 30 2001;98(3):1267-72. doi:10.1073/pnas.031461598 89. Jamin N, et al. Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor. Mol Endocrinol. Mar 2005;19(3):588-94. doi:10.1210/ me.2004-0308 90. Jaipuria G, et al. Cholesterol-mediated allosteric regulation of themitochondrial translocator protein structure. Nat Commun. Mar 30 2017;8:14893. doi:10.1038/ncomms14893 91. Jaremko L, et al. Structure of the mitochondrial translocator protein in complex with a diagnostic ligand. Science. Mar 21 2014;343(6177):1363-6. doi:10.1126/science.1248725 92. Li F, et al. Protein structure. Crystal structures of translocator protein (TSPO) and mutant mimic of a human polymorphism. Science. Jan 30 2015;347(6221):555-8. doi:10.1126/ science.1260590 93. Korkhov VM, et al. Three-dimensional structure of TspO by electron cryomicroscopy of helical crystals. Structure. Jun 9 2010;18(6):677-87. doi:10.1016/j. str.2010.03.001 94. Iatmanen-Harbi S, et al. Characterization of the High-Affinity Drug Ligand Binding Site of Mouse Recombinant TSPO. Int J Mol Sci. Mar 21 2019;20(6) doi:10.3390/ijms20061444 95. Guo Y, et al. Protein structure. Structure and activity of tryptophan-rich TSPO proteins. Science. Jan 30 2015;347(6221):551-5. doi:10.1126/science. aaa1534 96. JaipuriaG, et al. Insights intoCholesterol/Membrane Protein Interactions Using Paramagnetic Solid-State NMR. Chemistry. Nov 27 2018;24(66):1760617611. doi:10.1002/chem.201804550 97. Taylor JM, et al. Targeting mitochondrial 18 kDa translocator protein (TSPO) regulates macrophage cholesterol efflux and lipid phenotype. Clin Sci (Lond). Nov 2014;127(10):603-13. doi:10.1042/ CS20140047 98. Biswas L, et al. Retinal pigment epithelium cholesterol efflux mediated by the 18 kDa translocator protein, TSPO, a potential target for treating age-related macular degeneration. Hum Mol Genet. Nov 15 2017;26(22):4327-4339. doi:10.1093/hmg/ddx319 99. Elustondo P, et al. Mitochondrial cholesterol import. Biochim Biophys Acta Mol Cell Biol Lipids. Jan 2017;1862(1):90-101. doi:10.1016/j. bbalip.2016.08.012 100. Rone MB, et al. Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states. Biochim Biophys Acta. Jul 2009;1791(7):646-58. doi:10.1016/j. bbalip.2009.03.001 101.Mari M, et al. Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal. Nov 2009;11(11):2685-700. doi:10.1089/ ARS.2009.2695 102. Gatliff J, et al. TSPO is a REDOX regulator of cell mitophagy. BiochemSoc Trans. Aug 2015;43(4):54352. doi:10.1042/BST20150037 103. Gatliff J, et al. A role for TSPO in mitochondrial Ca(2+) homeostasis and redox stress signaling. Cell Death Dis. Jun 22 2017;8(6):e2896. doi:10.1038/ cddis.2017.186
RkJQdWJsaXNoZXIy MTk4NDMw